123 related articles for article (PubMed ID: 18585693)
1. Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice.
Cotel MC; Bayer TA; Wirths O
Brain Res; 2008 Jul; 1222():207-13. PubMed ID: 18585693
[TBL] [Abstract][Full Text] [Related]
2. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
[TBL] [Abstract][Full Text] [Related]
3. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
[TBL] [Abstract][Full Text] [Related]
4. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
[TBL] [Abstract][Full Text] [Related]
5. Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairment.
Bayer TA; Wirths O
Genes Brain Behav; 2008 Feb; 7 Suppl 1():6-11. PubMed ID: 18184366
[TBL] [Abstract][Full Text] [Related]
6. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
[TBL] [Abstract][Full Text] [Related]
7. Presenilin 1-related alterations in DNA integrity in a transgenic mouse model of Alzheimer's disease.
Michelsen KA; Korr H; Steinbusch HW; Schmitz C
Brain Res; 2010 Feb; 1316():139-44. PubMed ID: 20034479
[TBL] [Abstract][Full Text] [Related]
8. Intraneuronal beta-amyloid is a major risk factor--novel evidence from the APP/PS1KI mouse model.
Bayer TA; Breyhan H; Duan K; Rettig J; Wirths O
Neurodegener Dis; 2008; 5(3-4):140-2. PubMed ID: 18322372
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
[TBL] [Abstract][Full Text] [Related]
10. The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease.
Hamilton A; Holscher C
Brain Res; 2012 Apr; 1449():83-93. PubMed ID: 22418058
[TBL] [Abstract][Full Text] [Related]
11. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
12. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
[TBL] [Abstract][Full Text] [Related]
13. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
[TBL] [Abstract][Full Text] [Related]
14. Extracellular amyloid-beta and cytotoxic glial activation induce significant entorhinal neuron loss in young PS1(M146L)/APP(751SL) mice.
Moreno-Gonzalez I; Baglietto-Vargas D; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Del Rio JC; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
J Alzheimers Dis; 2009; 18(4):755-76. PubMed ID: 19661615
[TBL] [Abstract][Full Text] [Related]
15. The effect of amyloidosis-beta and ageing on proliferation of neuronal progenitor cells in APP-transgenic mouse hippocampus and in culture.
Kolecki R; Lafauci G; Rubenstein R; Mazur-Kolecka B; Kaczmarski W; Frackowiak J
Acta Neuropathol; 2008 Oct; 116(4):419-24. PubMed ID: 18483741
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease.
Wirths O; Thelen K; Breyhan H; Luzón-Toro B; Hoffmann KH; Falkai P; Lütjohann D; Bayer TA
Exp Gerontol; 2006 Feb; 41(2):220-4. PubMed ID: 16307858
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.
Christensen DZ; Bayer TA; Wirths O
Neurobiol Aging; 2010 Jul; 31(7):1153-63. PubMed ID: 18771817
[TBL] [Abstract][Full Text] [Related]
18. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease.
Wirths O; Breyhan H; Schäfer S; Roth C; Bayer TA
Neurobiol Aging; 2008 Jun; 29(6):891-901. PubMed ID: 17215062
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes of neuron numbers in the frontal cortex of a transgenic mouse model of Alzheimer's disease.
Lemmens MA; Sierksma AS; Rutten BP; Dennissen F; Steinbusch HW; Lucassen PJ; Schmitz C
Brain Struct Funct; 2011 Sep; 216(3):227-37. PubMed ID: 21409417
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice.
Bronfman FC; Moechars D; Van Leuven F
Neurobiol Dis; 2000 Jun; 7(3):152-68. PubMed ID: 10860782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
